Synthetic Angiotensin II/Giapreza in Pediatric Patients With Refractory Hypotension
NCT07212686
·
clinicaltrials.gov ↗
PHASE4
Phase
ENROLLING_BY_INVITATION
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Vasodilatory Shock
Interventions
DRUG:
Angiotensin-II
Sponsor
Todd Sweberg
Collaborators
[object Object]